Mingfang Ji

1.7k total citations
48 papers, 713 citations indexed

About

Mingfang Ji is a scholar working on Oncology, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, Mingfang Ji has authored 48 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 14 papers in Molecular Biology and 12 papers in Otorhinolaryngology. Recurrent topics in Mingfang Ji's work include Viral-associated cancers and disorders (17 papers), Head and Neck Cancer Studies (12 papers) and Cancer-related molecular mechanisms research (7 papers). Mingfang Ji is often cited by papers focused on Viral-associated cancers and disorders (17 papers), Head and Neck Cancer Studies (12 papers) and Cancer-related molecular mechanisms research (7 papers). Mingfang Ji collaborates with scholars based in China, Hong Kong and Sweden. Mingfang Ji's co-authors include Honglin Chen, Jinsheng Liang, S.P. Ng, Kwok Hung Chan, Jonathan S. T. Sham, Yu Xia, Yanxing Yu, WI Wei, M.H. Ng and Daniel T. T. Chua and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Cancer.

In The Last Decade

Mingfang Ji

40 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingfang Ji China 14 393 259 187 135 102 48 713
Yong‐sheng Zong China 10 505 1.3× 73 0.3× 91 0.5× 135 1.0× 89 0.9× 29 618
Victor Lopes United Kingdom 10 147 0.4× 281 1.1× 125 0.7× 92 0.7× 102 1.0× 16 646
Makiko Moriyama‐Kita Japan 12 161 0.4× 172 0.7× 105 0.6× 61 0.5× 52 0.5× 28 353
Pawan Upadhyay India 9 139 0.4× 203 0.8× 166 0.9× 28 0.2× 71 0.7× 24 460
Hamda Al-Thawadi Qatar 12 230 0.6× 119 0.5× 108 0.6× 32 0.2× 148 1.5× 25 426
Siti Mazlipah Ismail Malaysia 14 162 0.4× 227 0.9× 94 0.5× 75 0.6× 21 0.2× 37 501
Robert Saddawi‐Konefka United States 13 299 0.8× 207 0.8× 54 0.3× 48 0.4× 38 0.4× 32 774
Piotr Wysocki Poland 10 310 0.8× 189 0.7× 84 0.4× 20 0.1× 30 0.3× 20 548
Hari Nadiminti United States 8 121 0.3× 95 0.4× 54 0.3× 47 0.3× 64 0.6× 15 358
Timothy Brennan United States 6 146 0.4× 221 0.9× 80 0.4× 89 0.7× 39 0.4× 13 587

Countries citing papers authored by Mingfang Ji

Since Specialization
Citations

This map shows the geographic impact of Mingfang Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfang Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfang Ji more than expected).

Fields of papers citing papers by Mingfang Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingfang Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfang Ji. The network helps show where Mingfang Ji may publish in the future.

Co-authorship network of co-authors of Mingfang Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Mingfang Ji. A scholar is included among the top collaborators of Mingfang Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingfang Ji. Mingfang Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhuang, Chunlan, Yue Huang, Fan Liu, et al.. (2025). Preliminary Cost-effectiveness and Cost-utility of Nasopharyngeal Carcinoma Screening with the Novel Biomarker Anti-BNLF2b Total Antibody. Cancer Epidemiology Biomarkers & Prevention. 34(12). 2239–2246.
2.
3.
4.
5.
Hu, Yin, Yubin Hou, Xingkai Wang, et al.. (2025). Delocalized electrolyte design enables 600 Wh kg−1 lithium metal pouch cells. Nature. 644(8077). 660–667. 12 indexed citations
6.
Cao, Su‐Mei, Mingfang Ji, Yong‐Qiao He, & Wei‐Hua Jia. (2024). Epidemiological studies of Epstein-Barr virus and associated diseases. Scientia Sinica Vitae. 54(12). 2224–2244. 1 indexed citations
7.
8.
Lu, Chenyu, Fugui Li, Xuejun Liang, et al.. (2024). Monitoring Hepatocellular Carcinoma Using Tumor Content in Circulating Cell-Free DNA. Clinical Cancer Research. 30(13). 2772–2779. 3 indexed citations
9.
Lu, Chenyu, Fugui Li, Limei Ai, et al.. (2024). Circulating DNA genome-wide fragmentation in early detection and disease monitoring of hepatocellular carcinoma. iScience. 27(5). 109701–109701. 2 indexed citations
10.
Chen, Mengting, et al.. (2024). Cepharanthine as an effective small cell lung cancer inhibitor: integrated insights from network pharmacology, RNA sequencing, and experimental validation. Frontiers in Pharmacology. 15. 1517386–1517386. 1 indexed citations
11.
Chang, Ellen T., Fugui Li, Kuangrong Wei, et al.. (2023). Pre-diagnostic anti-EBV antibodies and primary liver cancer risk: a population-based nested case-control study in southern China. BMC Cancer. 23(1). 250–250. 1 indexed citations
12.
Liu, Junxian, Tingdong Li, Mingfang Ji, & Ningshao Xia. (2023). Novel antibody biomarker P85-Ab improved the performance of nasopharyngeal carcinoma screening. Chinese Science Bulletin (Chinese Version). 69(4-5). 479–481. 1 indexed citations
13.
Zhang, Wentong, Lei Feng, Yu Xia, et al.. (2020). <p>Long-Term Survival After Nasopharyngeal Carcinoma Treatment in a Local Prefecture-Level Hospital in Southern China</p>. Cancer Management and Research. Volume 12. 1329–1338. 4 indexed citations
14.
Xia, Yu, Fugui Li, Fuzhen Xia, et al.. (2020). Efficacy of Chemiluminescence Immunoassays on VCA-IgA and EBNA1-IgA Antibodies of Epstein-Barr Virus in Diagnosing Nasopharyngeal Carcinoma. Journal of Cancer. 11(24). 7176–7183. 6 indexed citations
15.
Xia, Yu, et al.. (2019). A Retrospective Cohort Study of Nasopharyngeal Carcinoma Screening and Hepatocellular Carcinoma Screening in Zhongshang City. Journal of Cancer. 10(8). 1909–1914. 3 indexed citations
16.
Gao, Fei, et al.. (2015). Investigations into the association between polymorphisms in the interleukin-10 gene and risk of early-onset preeclampsia. Genetics and Molecular Research. 14(4). 19323–19328. 13 indexed citations
17.
Li, Lili, Mingfang Ji, Yingduan Cheng, et al.. (2013). FEZF2 , a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma. Carcinogenesis. 34(9). 1984–1993. 38 indexed citations
18.
Xia, Yu, et al.. (2011). Epidemiological study of epstein-barr virus infection for nasopharyngeal carcinoma screening in high-incidence areas. Clinical Oncology and Cancer Research. 38(24). 1551–1554. 1 indexed citations
19.
Ji, Mingfang, et al.. (2011). Detection of Stage I nasopharyngeal carcinoma by serologic screening and clinical examination. Chinese Journal of Cancer. 30(2). 120–123. 16 indexed citations
20.
Ji, Mingfang, et al.. (2002). [Detection of serum Epstein-Barr virus antibody level by ELISA in normal populations and nasopharyngeal carcinoma patients in Zhongshan City of China].. PubMed. 22(9). 817–8, 822.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong‐sheng Zong Breakdown of academic impact, for papers by Victor Lopes Breakdown of academic impact, for papers by Makiko Moriyama‐Kita Breakdown of academic impact, for papers by Pawan Upadhyay Breakdown of academic impact, for papers by Hamda Al-Thawadi Breakdown of academic impact, for papers by Siti Mazlipah Ismail Breakdown of academic impact, for papers by Robert Saddawi‐Konefka Breakdown of academic impact, for papers by Piotr Wysocki Breakdown of academic impact, for papers by Hari Nadiminti Breakdown of academic impact, for papers by Timothy Brennan
Rankless by CCL
2026